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Précis:  
Low concentrations of vitamin D3 were associated with lower HDL-C concentrations and a 
worsening lipid profile when monkeys were fed a moderately atherogenic diet.   
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Abstract:   
 
Objective: To investigate plasma concentrations of vitamin D and the association with plasma 
lipid profiles. Methods: Plasma vitamin D3 and lipid concentrations were measured in 119 
female cynomolgus monkeys (premenopausal n=49; ovariectomized n=70) consuming 1,000 
IU/day of vitamin D3. In a subset of the ovariectomized monkeys (n=23), Vitamin D3 was re-
measured after 6 months. Concentrations of vitamin D3 were analyzed as a continuous variable 
and were divided at the median into higher (High, ≥48 ng/mL) vs. lower (Low, <48 ng/mL) 
groupings. Results: Among the 119 monkeys, the range of vitamin D3 concentrations was 24.0 
to 95.2 ng/mL (mean ± SD = 48.5 ± 12.7 ng/mL). Plasma vitamin D3 concentration was 
positively associated with high density lipoprotein cholesterol (HDL-C) (p=0.003). Monkeys in 
the High vitamin D3 group had a significantly greater plasma HDL-C concentration (57.9 mg/dL) 
than those in the Low vitamin D3 group (47.1 mg/dL, p=0.001). Although the difference was not 
significant (p=0.120), monkeys in the High Vitamin D3 group had a decreased total plasma 
cholesterol (TPC)/HDL-C ratio compared with the low Vitamin D3 group (5.4 and 6.2, 
respectively), potentially putting them at lower risk for atherosclerosis development.  
Conclusions: Given that the monkeys all consumed a diet replete in vitamin D3, it appears that 
individual differences in vitamin D absorption or metabolism may have determined whether the 
monkeys had high or low concentrations of vitamin D3. Lower vitamin D3 was associated with a 
more atherogenic lipid profile, a major risk factor for progressing to coronary artery 
atherosclerosis in monkeys and human beings. 
 
 
Key Words: Cardiovascular / Coronary Heart Disease; Vitamin D Concentrations; High Density 
Lipoprotein; Lipid Profiles; Menopause 
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Introduction: 
 
It has been known for many years that vitamin D is necessary in maintaining bone health 
by promoting intestinal absorption of calcium and phosphorus.1 Vitamin D also is essential for 
the prevention of rickets2 and osteoporosis.3 For these reasons, the prevalence of vitamin D 
deficiency is an important health issue. According to the Third National Health and Nutrition 
Examination Survey (NHANES III), vitamin D deficiency is present in 25% to 57% of American 
adults.4 Additional studies indicate similar deficiencies in children, adolescents, and elderly 
populations.5,6 In the past, a deficiency has been defined as having a plasma 25(OH)D level 
below 15 ng/mL. A higher risk of deficiency is posed to individuals of darker skin pigmentation 
and individuals who live at higher latitudes due to decreased sun exposure.7 Current data suggest 
that plasma 25(OH)D concentrations should be >30 ng/mL, and ideally 36-40 ng/mL for 
improved health outcomes.8 Achieving these levels may require increasing daily vitamin D 
intake to 600-800 IU per day8-10 as opposed to previous dietary standards which suggested 400 
IU per day for individuals younger than 70 and 600 IU for individuals 70 or older.11 
The results of more recent studies have suggested that additional benefits of vitamin D 
include improved overall health and chronic disease prevention. Vitamin D has been associated 
with the prevention of rectal cancer,12 prostate cancer,13 and breast cancer.14 In addition to cancer 
prevention, Vitamin D has links to prevention of autoimmune diseases, such as multiple 
sclerosis15 and rheumatoid arthritis,16 along with type I17 and type II diabetes.18 
Coronary heart disease (CHD) also has been linked to a deficiency in Vitamin D. Well-
documented risk factors for CHD include tobacco use, hypercholesterolemia, hypertension, 
obesity, diabetes mellitus, gender specific age, and a family history of CHD.19,20 The findings of 
a recent study showed an inverse relationship between low plasma 25(OH)D concentrations (<15 
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ng/mL) and first-time cardiovascular events with an increased hazard ratio of 1.6 to 2.1.21 The 
results of other studies have shown a higher incidence of hypertension and CHD in higher 
latitudes suggesting that those with lower exposure to sunlight, and hence lower vitamin D 
concentrations, may have a higher risk of heart disease.22,23 CHD,24 myocardial infarction,25 
sudden cardiac death,26 stroke,27 peripheral arterial disease,28 greater carotid intima-media 
thickness,29 and hypertension30 all have been associated with low plasma 25(OH)D levels. 
Despite an extensive search, we were able to find only a few articles analyzing the 
relationship between vitamin D and plasma cholesterol. The results of several older studies 
suggested higher vitamin D concentrations were associated with worsening cholesterol 
parameters31,32, while a few newer studies have suggested improved parameters.21,22 One report 
found that higher concentrations of vitamin D may be associated with a lower total plasma 
cholesterol (TPC) to high density lipoprotein cholesterol (HDL-C) ratio (TPC/HDL-C).21 The 
results of another investigation showed lower triglyceride (TG) concentrations in those with 
higher vitamin D measurements.33 We identified two reports suggesting an association between 
higher vitamin D concentrations and increased HDL-C34,35 as well as a lower prevalence of 
metabolic syndrome34, major determinants of CHD risk. However, these studies showing 
cholesterol improvement have potential confounding factors including compliance, recall bias, 
variations in ethnicity and other factors associated with population-based studies.21,33 For these 
reasons, new suggestions that vitamin D supplementation is mostly unnecessary9,10, along with 
the Institute of Medicine’s challenge to continue targeted research related to vitamin D10, the 
objective of this research was to investigate the relationship between vitamin D and plasma lipid 
concentrations. More specifically, we sought to evaluate whether, and to what extent, low plasma 
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concentrations of vitamin D are associated with a more atherogenic plasma lipid profile in a 
cohort of female cynomolgus monkeys. 
 
 
Methods:  
 
Animals and Diets: 
The study utilized a total of 119 female cynomolgus monkeys (Macaca fascicularis) 
which were imported from Institute Pertanian Bogor in West Java, Indonesia (the Indonesian 
Primate Center, i.e., the Pusat Studi Satwa Primata). To increase the translational value of the 
study and to recreate the variations in human exposures (hormonal, dietary, and sun exposure), 
the monkeys studied represented both premenopausal and surgically postmenopausal subjects, 
monkeys that had consumed a moderately atherogenic diet for a relatively long period (26 
months) and a relatively short period (4 months) and were housed either indoors or indoors with 
access to an outdoor run (indoor-outdoor). All of the monkeys were determined to be adult (i.e., 
middle aged and beyond), and all consumed the same amount of vitamin D3 (a woman’s 
equivalent of 1,000 IU/day). Of the total 119 monkeys, 49 were premenopausal and 70 were 
post-menopausal (ovariectomized). All monkeys were socially housed with 2-5 monkeys per 
pen. The indoor-outdoor housing group consisted of 50 ovariectomized monkeys. The indoor 
housing group (n=49 premenopausal, n=20 ovariectomized) was housed in a facility with large 
tinted windows along both sides of the building to allow light, but to screen out some of the 
direct ultraviolet sunlight. All monkeys were fed a controlled diet which was prepared in the 
animal diet laboratory at the Wake Forest University Primate Center and were formulated to be 
equivalent for cholesterol, macronutrient content (i.e., protein, fat, carbohydrate), and vitamin 
D3.  
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All procedures involving animals in this study were conducted in compliance with state 
and federal laws, standards of the US Department of Health and Human Services (DHHS), and 
guidelines established by the Wake Forest University Institutional Animal Care and Use 
Committee (IACUC) where the animals were housed. 
 
Vitamin D Measurement: 
Plasma vitamin D3 concentrations were measured in all of the 119 female cynomolgus 
monkeys (premenopausal n=49; ovariectomized, n=70) at a single time point. A subset of the 
ovariectomized monkeys had vitamin D3 re-measured after 6 months (n=23). All vitamin D 
assays were done at The Reading Hospital and Medical Center. Frozen samples (500 µL) were 
transported to The Reading Hospital and Medical Center and protected from direct sunlight, a 
technique which has been shown to yield stable results.36 We utilized the HPLC/tandem mass 
spectrometry for the 25(OH)D assay, with a determination for D3. Our approach utilized the 
Shimadzu liquid chromatography - mass spectrometry/mass spectrometry (LC-MS/2) 
technology. The liquid chromatography - mass spectrometry prepares the sample to be ionized, 
through physical separation capabilities of liquid chromatography, for mass analysis by injection 
into the AB Sciex 3200 Q Trap mass spectrometer. 
 
Plasma Lipids: 
Plasma lipid and lipoproteins and body weight were measured at the time of Vitamin D3 
measurement. All lipid measurements were done in the Clinical Chemistry Laboratory at the 
Wake Forest University Primate Center. The determinations included total plasma cholesterol 
(TPC), high density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (VLDL-C + LDL-C) 
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and plasma triglycerides (TGs). Cholesterol and triglyceride analyses were done using enzymatic 
methods on the COBAS FARA II analyzer, with protocols and reagents supplied by Boehringer 
Mannheim. The Clinical Chemistry Laboratory was fully standardized with this method and is in 
the continuing surveillance phase of the CDC Lipid Standardization Program. HDL-C 
concentrations were determined using the heparin-manganese precipitation procedure37 and are 
described in detail in the Manual of Laboratory Operations of the Lipid Research Clinics 
Program38. In addition to the baseline measurements, 23 of the monkeys had follow-up plasma 
lipid measurements after receiving an additional 6 months of the moderately atherogenic diet. 
 
Statistical Analysis:  
Descriptive statistics including medians, means and standard deviations were used to 
describe the body weight data. Arithmetic means were used to describe measured values 
including: TG, HDL-C, TPC, and VLDL-C + LDL-C. For calculated values (e.g., TPC/HDL-C 
ratios), geometric means were calculated. Vitamin D3 concentrations and plasma lipids were 
assessed for normality of distribution and analyzed as continuous variables. Vitamin D3 values 
were dichotomized into higher and lower concentrations using the median vitamin D3 
concentration of 48 ng/mL.  
To determine the pathologic significance of the TPC/HDL-C ratios for monkeys in the 
upper half of the distribution of plasma concentrations of vitamin D compared with those in the 
lower half of the distribution (TPC:HDL-C, 6.2 vs. 5.4, respectively), we used a separate 
database from a study reported previously39. In that study, data were available regarding the 
relationship between plasma TPC/HDL-C and the extent of atherosclerosis found in the iliac 
arteries of 103 subjects. Iliac artery plaque size (intimal area) was expressed as cross-sectional 
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area in mm2. Based on the pathologic convention that intimal areas of ≤0.2 mm2 equate with 
fatty streaks and intimal areas >0.2 mm2 are considered plaques, we determined the relationship 
between plasma TPC/HDL-C ratios and the individual cases that had fatty streaks vs. those with 
plaques (figure 1). 
Inferential statistics consisted of Student t-tests to compare lipid profiles by vitamin D3 
group (High vs. Low), all lipid and D3 values by pre- and post-menopausal status, and type of 
housing. For comparison of lipid profiles and vitamin D3 concentrations of the entire cohort 
(n=119), Pearson’s correlation coefficient was used to generate r values for continuous variables. 
Correlations between variables and high and low vitamin D3 values were analyzed using 
Spearman’s ranked correlation coefficient to generate rho values.  
All analyses were conducted using an a priori alpha level of 0.05 such that results 
yielding p<0.05 were deemed statistically significant. SPSS v. 17.0 (SPSS Inc., Chicago, IL 
2009) was used for all analyses.  
 
Results:  
Housing Condition: 
Housing condition (indoor vs. indoor /outdoor) had a significant effect on plasma vitamin 
D3 concentrations (p<0.001). The mean (± SD) for the monkeys housed indoors was 44.68 ± 
9.14 ng/mL (range 24 to 64); whereas those with access to outdoor pens was 53.87 ± 14.96 
ng/mL (range 26 to 95). 
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Time Consuming an Atherogenic Diet: 
As expected, the length of time the monkeys consumed an atherogenic diet may have 
influenced their HDL-C concentrations. The monkeys that consumed the diet for 26 months had 
a mean HDL-C concentration of 46.35 ± 15.33 mg/dL, whereas those that consumed the diet for 
4 months had a mean of 61.04 ± 18.89 mg/dL (p<0.001). 
 
The Entire Cohort: 
Among the entire 119 monkeys fed an adequate and consistent quantity of vitamin D3, 
some with and some without exposure to sunlight, the range of vitamin D3 concentrations was 
24.0 to 95.2 ng/mL (mean ± SD = 48.5 ± 12.7 ng/mL) (figure 2). The body weight (BW) 
distribution ranged from 2.12 to 4.46 kg (mean ± SD, 2.97 ± 0.46 kg).  
Analyzing vitamin D3 as a continuous variable, plasma vitamin D3 concentration was 
positively associated with HDL-C (r=0.28, p=0.003) (figure 3). In contrast, there were no 
significant associations between the vitamin D3 concentrations and any of the following: BW, 
TPC, TG, VLDL+LDL-C, or TPC/HDL-C ratio. Those with vitamin D3 concentrations ≥48 
ng/mL, compared to those with vitamin D3 concentrations <48 ng/mL, showed no significant 
differences in BW, TPC, TG, or VLDL+LDL-C. Conversely, monkeys with vitamin D3 
concentrations ≥48 ng/mL had a significantly higher plasma HDL-C than those with vitamin D3 
concentrations <48 ng/mL (57.9 mg/dL vs. 47.1 mg/dL, respectively; p=0.001) (figure 4). 
Although the difference was not significant (p=0.120), monkeys with vitamin D3 concentrations 
≥48 ng/mL had a lower TPC/HDL-C ratio than those <48 ng/mL, (5.4 and 6.2, respectively) 
(figure 4).  
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The difference between the TPC/HDL-C ratio in those with lower vs. higher vitamin D3 
concentrations appeared large, but did not meet statistical significance. A post hoc power 
analysis showed that a total sample size of 380, or 190 in each group (divided at the median), 
would afford 80% power to detect a difference in means of 0.88 (the difference between a Group 
1 TPC/HDL-C ratio of 6.2 and a Group 2 TPC/HDL-C ratio of 5.4) assuming that the common 
standard deviation was 3.0, using a two-group t-test with a 0.05 two-sided significance level. 
 There were 23 ovariectomized monkeys fed the moderately atherogenic diet for 4 months 
that were followed prospectively with additional plasma lipid measurements 6 months later. As 
expected with additional months of diet, all variables, with the exception of triglyceride, moved 
in the direction of a more atherogenic plasma lipid profile. However, the finding that monkeys 
with higher plasma vitamin D3 concentrations (High group) tended to have lower adverse 
changes in plasma lipids than those with lower values (Low group) was unexpected, although 
these relationships did not reach statistical significance. TPC increased 35.3% versus 45.9% in 
the high versus low vitamin D concentration groups, respectively. Likewise, the LDL-C + 
VLDL-C concentrations increased 49.3% versus 63.9%, the HDL-C decreased 12.1% versus 
17.1% while the TPC/HDL-C ratio increased by 2.9 versus 4.3, all in the high versus low vitamin 
D concentration groups, respectively (table 1).  
The TPC/HDL-C ratio for both the Low and High plasma vitamin D cohorts was 4.8 
(n=23). After six months of consuming a moderately atherogenic diet, the ratio was 9.1 in the 
low vitamin D group compared with 7.7 in the high vitamin D group. In our analysis of a 
separate database, from a study published previously39, we considered the significance of the 
TPC/HDL-C ratio. From that database, we determined that the progression of atherosclerosis 
(defined as an intimal area of >0.2 mm2) begins at a TPC/HDL-C ratio of approximately 6, and 
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there was a strong and highly significant correlation between intimal area and TPC/HDL-C ratio 
(r=0.489, p<0.001) (Figure 1). Taken together, these findings suggest that vitamin D modulated 
differences in the TPC/HDL-C ratio may affect atherosclerosis progression and thus have clinical 
significance. 
 
 
Discussion: 
Despite an abundance of data suggesting an association between low vitamin D3 and 
CHD risk21-30, recent data have challenged this belief9,10,40. A report from the Women’s Health 
Initiative (WHI), looking at calcium and vitamin D supplementation and its link to the 
prevention of coronary artery calcification, showed no significant effect. It should be noted, 
however, that patients were receiving only 400 IU of vitamin D3 per day40. In addition, plasma 
vitamin D concentrations were not known, compliance was known to be poor, and patients were 
allowed to continue their baseline vitamin supplementation.  Current data suggest that the daily 
vitamin D intake should be at least 600-800 IU per day for better health outcomes.8-10  
In the study presented here, a large variation in plasma vitamin D3 concentrations (24.0 to 
95.2 ng/mL) was observed, in a cynomolgus monkey population in which all monkeys were 
consuming a diet nearly equivalent in cholesterol, protein, fat, carbohydrates, and vitamin D 
(1,000 IU human equivalents) at the time of sampling. We question whether these differences 
may be due, at least in part, to genetic variations in vitamin D metabolism (although the time on 
each diet and environmental factors likely played a role as well). While variations in absorption 
could also play a role, it would seem unlikely to have such a high prevalence of poor vitamin D 
absorption in this cohort of monkeys. The wide variation also raises the question as to the 
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usefulness of 1,000 IU of vitamin D supplementation in those with low levels. In other words, it 
is not known whether supplementing low vitamin D concentrations in general, or even with 
1,000 IU, makes a clinically meaningful impact, or whether low vitamin D concentrations are a 
marker for other processes (potentially unrelated to vitamin D supplementation). Therefore, this 
finding warrants further study related to vitamin D supplementation and its effects. It is 
interesting to note that despite a paucity of data or understanding of what vitamin D 
supplementation does, it is becoming a more popular phenomenon to test and aggressively treat 
decreased plasma vitamin D concentrations. 
The current study demonstrates an association between low plasma concentrations of 
vitamin D and a more atherogenic lipid profile. The major findings, therefore, propose an 
explanation for why vitamin D-deficient individuals may be at increased risk for CHD. In our 
sample, cynomolgus monkeys with higher plasma vitamin D concentrations had significantly 
higher HDL-C levels (figure 3 and 4).  These findings suggest that low HDL-C levels, one of the 
well recognized risk factors for CHD, may be causally linked to a deficiency in vitamin D in the 
monkey model. The monkeys with higher plasma concentrations of vitamin D also had a lower 
TPC/HDL-C ratio (figure 4). TPC/HDL-C ratios greater than 6.0, based on our additional 
analysis, are shown to be highly atherogenic in this model (figure 1). An increasingly higher 
TPC/HDL-C ratio, as shown in figure 1, is correlated with a greater plaque size, suggesting a 
worsening risk with increasing TPC/HDL-C ratios. The fact that monkeys in the higher vitamin 
D group had TPC/HDL-C ratios <6, while those in the lower vitamin D range had ratios >6, 
although not statistically significant, has clinical implications. These findings, in combination 
with greater HDL-C values in the higher vitamin D cohort (p=0.001), provide evidence for a 
more favorable lipid profile in those monkeys with higher vitamin D concentrations.  
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A subset of 23 monkeys, followed prospectively for 6-month changes in their lipid 
profiles, revealed interesting findings (table 1). Although none of the differences were 
statistically significant (largely due to the small sample size), it is noteworthy that the changes, 
evaluated as both actual and percentage differences, were all lower in the monkeys with higher 
baseline vitamin D concentrations. A post hoc power analysis determined the need for at least 38 
monkeys to have 80% power to be able to detect a statistically significant difference in these 
parameters. While the findings are not statistically significant, the consistency of the finding 
along with the degree of disparity in the percent change may imply clinical relevance. This could 
imply that higher vitamin D concentrations may help abate the development of an atherogenic 
lipid profile, despite a high-fat diet. 
 A study of human subjects which determines if and to what extent HDL-C levels increase 
and TPC/HDL-C ratios decrease with vitamin D supplementation would be clinically beneficial. 
Additionally, it would be helpful to analyze the role of further supplementation and more 
specifically, the response of cholesterol measurements when Vitamin D supplementation is 
sequentially increased. With adequate and maximal dosing, what is the vitamin D response and 
does it vary widely among individuals? Further studies should also analyze whether patients who 
are hypercholesterolemic benefit from vitamin D assessment, both in lipid parameters and 
measures of atherosclerosis.  
The variation in HDL-C concentrations and vitamin D3 concentrations based on diet and 
housing, respectively, is not surprising. We expected a worsening lipid profile in those monkeys 
with a larger exposure to a moderately atherogenic diet. Likewise, we expected higher vitamin 
D3 concentrations in those monkeys with outdoor exposure. Differences in the time on diet and 
housing arrangements helped create a more realistic translational model that gave the necessary 
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distribution of study variables. The small population size of cynomolgus monkeys could have 
prohibited our ability to see significant differences due to a low power and hence a beta (Type II) 
error. Studies to confirm these results in a human cohort would be helpful. However, the 
cynomolgus monkeys have been shown to be a reliable model to study potential causes of 
postmenopausal atherosclerosis41, a model in which standardized dosing, compliance, sun 
exposure, time of dosing, food intake, and plasma measurements can all be controlled. 
 
Conclusion: 
 Despite the limitations mentioned above, the clinical relevance of our findings is 
important. To the best of our knowledge, this is the first report suggesting lower HDL-C 
concentrations and a worsening lipid profile over time in association with low Vitamin D 
concentrations. It was also done in a way that controlled the sun exposure, diet, and vitamin D3 
intake. Given that all monkeys consumed a diet that was replete in vitamin D3, it appears that 
individual differences (presumably genetic) in vitamin D absorption or metabolism may have 
determined whether the monkeys had high or low plasma concentrations of vitamin D3. Lower 
concentrations of vitamin D3 were associated with significantly lower concentrations of HDL-C, 
a higher TPC/HDL-C ratio, and an enhancement of the adverse lipid effects of a moderately 
atherogenic diet, all established risk factors for progressive coronary artery atherosclerosis of 
both the monkey model and in women. The results add to existing knowledge by identifying 
vitamin D deficiency as a potential cause of atherogenic lipid parameters and increased CHD.    
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Table 1. Actual and percentage changes in lipid profiles after 6 months on a high-fat diet 
 
 Low Vitamin D* High Vitamin D* 
lipid parameter actual chg % chg actual chg % chg 
TPC (mg/dL) 117.9 45.9 92.7 35.3 
TG (mg/dL) -5.5 -10.6 -3.3 -7.7 
HDL-C (mg/dL) -9.8 -17.1 -7.3 -12.1 
LDL-C+VLDL-C (mg/dL) 127.7 63.9 100 49.3 
TPC/HDL-C ratio (units) 4.3 87.9 2.9 61.6 
 
*Low vitamin D was defined as a plasma vitamin D3 concentration less than the median (48 
ng/mL) while High vitamin D was defined as a plasma vitamin D3 concentration greater than or 
equal to the median. 
 
TPC: total plasma cholesterol  
TG: Plasma Triglyceride 
HDL-C: high density lipoprotein cholesterol  
LDL-C + VLDL-C: non HDL-C (or low density lipoprotein cholesterol and very low density  
         lipoprotein cholesterol)  
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Figure 1. This figure shows the progression of atherosclerosis as the TPC/HDL-C ratio increases. 
Plaques are defined as iliac artery intimal areas above 0.2 mm2; this figure suggests the 
TPC/HDL-C ratio at which the progression of atherosclerosis begins is 6. 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
0 5 10 15 20 25 30 35
TPC/HDL-C ratio (units)
In
tim
al
 
Ar
ea
 
(m
m
2 )
pl
a
qu
e
s 
→
←
 
st
re
a
ks
 
TPC/HDL-C – Total Plasma Cholesterol: High Density Lipoprotein ratio
 
 24 
Figure 2 Frequency of vitamin D3 concentrations in cynomolgus monkeys (Macaca fascicularis) 
after controlled diet consumption. 
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Figure 3. Vitamin D3 concentration as a function of baseline HDL-C (mg/dL) concentration in 
cynomolgus monkeys (Macaca fascicularis) after controlled diet consumption. 
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Figure 4. Mean HDL-C (mg/dL) concentration and TPC/HDL-C ratio for cynomolgus monkeys 
(Macaca fascicularis) with vitamin D3 concentrations ≥48 ng/mL and <48 ng/mL 
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